A Surprising GLP-1 ‘Side Effect?’ A Taste for High-End Chocolate
NewBeauty Facebook Pinterest Instagram Youtube find a doctor Face Adult Acne Antioxidants Anti-Aging Celebrity Chronic Skin Conditions Eye Hydration Hyperpigmentation Makeup View All Eyebrows Eye Color Foundation Fragrance Lip Color Makeovers Male Skin Care Peels Pre-Event Prep Retinoids Sensitive Skin Skin Care Skin Health Smile Sun Care Treatments Fillers Microneedling Post-Procedure Skin Care Neurotoxins Regenerative Aesthetics Skin Lifting Body Body Sculpting Breasts Butts Cellulite Hair Removal Hands + Nails Legs Pregnancy Find a Doctor Hair Bond Repair Celebrity Dry Hair Frizzy Hair Gray Hair Hair Color Hair Growth Hair Repair Scalp Health Styling + Tips Awards NB100 Awards 15th Annual Beauty Awards 2025 NewBeauty Readers’ Choice Awards Shopping Gift Guides Product Reviews NewBeauty Storefront Wellness Fitness GLP-1s Health Menopause About Us TESTTUBE Search for: Search HomeWellnessGLP-1s A Surprising GLP-1 ‘Side Effect?’ A Taste for High-End Chocolate New numbers suggest people are indulging more thoughtfully. Liz Ritter Published: Mar 15, 2026 Unsplash / Tetiana Bykovets During a recent press conference, Swiss chocolatier Lindt & Sprüngli had a message for those who believe GLP-1 medications dampen demand for chocolate delicacies: the data suggests otherwise. The premium chocolate maker reported double-digit organic growth in 2025, with sales climbing 12.4 percent to CHF 5.92 billion and operating profit reaching CHF 971 million. The results highlight the strength of the luxury chocolate category, even as the global confectionery industry grapples with record cocoa prices and economic uncertainty. Part of that growth came from price adjustments across the company’s portfolio. Lindt implemented average price increases of roughly 19 percent in 2025 to offset soaring cocoa costs, yet demand remained strong.